171 results
Page 5 of 9
424B5
7as2dkj eri4
25 Oct 13
Prospectus supplement for primary offering
12:00am
424B3
cxf5touc8s3j78y4 p0
24 Oct 13
Prospectus supplement
12:00am
8-K
EX-99.1
7sfq67xr4abd76n3wy74
24 Aug 12
Bristol-Myers Squibb Discontinues Development of BMS-986094, an Investigational NS5B Nucleotide for the Treatment of Hepatitis C
12:00am
8-K
EX-10.1
zcocet hfnoovz5u7gu
31 Jul 12
Entry into a Material Definitive Agreement
12:00am
424B5
c2ujo4g qfb6z9v4u5j
27 Jul 12
Prospectus supplement for primary offering
12:00am
424B3
qud0uamatahbruiohx3h
26 Jul 12
Prospectus supplement
12:00am
SC TO-T/A
EX-99
pzux0 hd96pl
23 Jul 12
Third party tender offer statement (amended)
12:00am